This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rama Iñiguez, S.
Right arrow Articles by Bolas-Fernández, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rama Iñiguez, S.
Right arrow Articles by Bolas-Fernández, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2006, p. 1195-1201, Vol. 50, No. 4
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.4.1195-1201.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Real-Time Reverse Transcription-PCR Quantification of Cytokine mRNA Expression in Golden Syrian Hamster Infected with Leishmania infantum and Treated with a New Amphotericin B Formulation

S. Rama Iñiguez,1,{dagger} M. A. Dea-Ayuela,1,{dagger} J. A. Sanchez-Brunete,2 J. J. Torrado,2 J. M. Alunda,3 and F. Bolas-Fernández1*

Departamento de Parasitología, Facultad de Farmacia, Universidad Complutense, Madrid, Spain,1 Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad Complutense, Madrid, Spain,2 Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense, Madrid, Spain3

Received 1 January 2006/ Returned for modification 10 January 2006/ Accepted 28 January 2006

A real-time quantitative reverse transcription-PCR assay was developed for the quantification of cytokine mRNA expression in the golden Syrian hamster Mesocricetus auratus infected with Leishmania infantum and treated with amphotericin B (AMB) formulated in microspheres made of human serum albumin (HSA). Treatment was administered intravenously on days 69, 71, and 73 postinfection (p.i.) with 107 metacyclic promastigotes, at doses of 2 and 40 mg/kg of AMB. High infection levels were recorded for untreated animals by day 76 p.i., with parasite loads always about 2 log10 per gram higher in the liver than in the spleen. Treatment was highly effective with both doses, but at 40 mg/kg, almost complete parasite elimination was achieved. mRNA expression of gamma interferon (IFN-{gamma}) and, to a lesser extent, tumor necrosis factor alpha (TNF-{alpha}) and transforming growth factor beta (TGF-ß) in spleen cells was up-regulated in most animals of the untreated group. The mRNA expression of interleukin-4 was strongly down-regulated in untreated as well as treated infected animals. Treatment with the lower dose of AMB-HSA down-regulated the mRNA expression of IFN-{gamma} and TNF-{alpha}, with no effect on the deactivating cytokine TGF-ß. In contrast, treatment with the higher dose (40 mg/kg) of the formulation caused moderate up-regulation of IFN-{gamma} and TNF-{alpha} and strong suppression of TGF-ß. Treatment of noninfected animals did not alter the cytokine expression pattern with regard to untreated controls. Our results suggest that treatment of L. infantum-infected Syrian hamsters with highly effective nontoxic doses of AMB-HSA causes deactivation of the anti-inflammatory cytokine TGF-ß, which in turn results in up-regulation of the Th1 cytokines IFN-{gamma} and TNF-{alpha}.


* Corresponding author. Mailing address: Departamento de Parasitología, Facultad de Farmacia, Universidad Complutense, Plaza de Ramón y Cajal s/n, Ciudad Universitaria, 28040 Madrid, Spain. Phone: 34 91 394 18 18. Fax: 34 91 394 18 15. E-mail: francisb{at}farm.ucm.es.

{dagger} S.R.I. and M.A.D.-A. participated equally in this paper.


Antimicrobial Agents and Chemotherapy, April 2006, p. 1195-1201, Vol. 50, No. 4
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.4.1195-1201.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Samant, M., Gupta, R., Kumari, S., Misra, P., Khare, P., Kushawaha, P. K., Sahasrabuddhe, A. A., Dube, A. (2009). Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of Leishmania donovani Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis. J. Immunol. 183: 470-479 [Abstract] [Full Text]  
  • Kim, C., Iseki, H., Herbas, M. S., Yokoyama, N., Suzuki, H., Xuan, X., Fujisaki, K., Igarashi, I. (2007). Development of Taqman-Based Real-Time PCR Assays for Diagnostic Detection of Babesia bovis and Babesia bigemina. Am J Trop Med Hyg 77: 837-841 [Abstract] [Full Text]